Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Synthesis and biological evaluation of DAPY–DPEs hybrids as non-nucleoside inhibitors of HIV-1 reverse transcriptase — Hai-Qiu Wu (2014) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Synthesis and biological evaluation of DAPY–DPEs hybrids as non-nucleoside inhibitors of HIV-1 reverse transcriptase
Shared by
De Clercq Erik
KU Leuven
Synthesis and biological evaluation of DAPY–DPEs hybrids as non-nucleoside inhibitors of HIV-1 reverse transcriptase
Article
2014
en
Authors
+5 more
HW
Hai-Qiu Wu
JY
Jin Yao
QH
Qiuqin He
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2013
Molecular design, synthesis and biological evaluation of BP-O-DAPY and O-DAPY derivatives as non-nucleoside HIV-1 reverse transcriptase inhibitors
Shiqiong Yang
,
Christophe Pannecouque
,
Dirk Daelemans
,
Xiaodong Ma
,
Yang Liu
,
Fen‐Er Chen
,
De Clercq Erik
Article
2014
Synthesis and biological evaluation of CHX-DAPYs as HIV-1 non-nucleoside reverse transcriptase inhibitors
Zihong Yan
,
Hai-Qiu Wu
,
Wenxue Chen
,
Yan Wu
,
Hu‐Ri Piao
,
Qiuqin He
,
Fen‐Er Chen
,
De Clercq Erik
,
Christophe Pannecouque
Article
2014
Synthesis and biological evaluation of new conformationally restricted S-DABO hybrids as non-nucleoside inhibitors of HIV-1 reverse transcriptase
Hai-Qiu Wu
,
Christophe Pannecouque
,
Zihong Yan
,
Wenxue Chen
,
Qiuqin He
,
Fen‐Er Chen
,
Jan Balzarini
,
Dirk Daelemans
,
De Clercq Erik
Article
2009
Synthesis and biological evaluation of imidazole thioacetanilides as novel non-nucleoside HIV-1 reverse transcriptase inhibitors
Peng Zhan
,
Xinyong Liu
,
Junjie Zhu
,
Zengjun Fang
,
Zhenyu Li
,
Christophe Pannecouque
,
De Clercq Erik
Article
2012
Synthesis and biological evaluation of piperidine-substituted triazine derivatives as HIV-1 non-nucleoside reverse transcriptase inhibitors
Xuwang Chen
,
Peng Zhan
,
Christophe Pannecouque
,
Jan Balzarini
,
De Clercq Erik
,
Xinyong Liu
Discussion(0)
No comments yet. Be the first to comment.